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ABSTRACT
COST-EFFECTIVENESS OF TELEHEALTH FOR CHRONIC CARDIOVASCULAR
CONDITIONS AND CHRONIC OBSTRUCTIVE PULMONARY DISEASE IN THE UNITED
STATES
By
TRISHNA KINI
May 29, 2019

INTRODUCTION: The United States has seen a dramatic increase in the incidence of chronic
disease, including chronic obstructive pulmonary disease (COPD) and chronic cardiovascular
diseases. Telehealth interventions can potentially improve healthcare access and health outcomes
in the United States while saving time and economic resources. Conclusive research is needed to
show whether telehealth interventions are cost-effective for people living with chronic disease.
AIM: This paper synthesizes the existing literature on the cost-effectiveness of telehealth
interventions for patients with chronic cardiovascular conditions (congestive heart failure (CHF),
myocardial infarctions, and coronary heart disease) and chronic obstructive pulmonary disease
(COPD).
METHODS: A literature search was undertaken to identify studies that assessed the costeffectiveness of telehealth interventions for chronic cardiovascular diseases and chronic
obstructive pulmonary disease (COPD) using PubMed and Scopus.
RESULTS: A thorough literature search using PubMed and Scopus identified 753 articles that
fit the search criteria. Of these, 27 articles met inclusion criteria, including 9 literature reviews
and 1 meta-analysis. Over 80% of the relevant research was conducted in Europe, Taiwan, and
Australia. The combination of a lack of cost-effectiveness research conducted in the United
States, methodological challenges in the existing studies, and continued technological
advancements, make it clear that further research is needed to make reliable inferences and
conclusions.
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I. Introduction
The United States has seen a dramatic increase in the incidence of chronic disease, including
chronic obstructive pulmonary disease (COPD) and chronic cardiovascular diseases such as
congestive heart failure (CHF) (Centers for Disease Control and Prevention, 2015). Many factors
have increased the incidence of chronic disease including social determinants of health (underlying
socioeconomic, cultural, political and environmental determinants) in addition to individual risk
factors (tobacco use, lack of physical exercise, unhealthy diet, age, and genetics) (World Health
Organization, 2005). Social determinants of health impact access and research has found that
poorer access to healthcare has contributed to the increase in chronic disease (Brooks et al., 2010).
Telehealth interventions can potentially improve healthcare access and health outcomes in the
United States while saving time and economic resources. Telehealth provides the option to deliver
health services to patients remotely through telecommunication technologies such as web-based
video chat capabilities, telephone consultations, and at-home monitoring (Botsis and Hartvigsen,
2008). Since people do not have to travel as far or as often to see a doctor, telehealth has the
potential toincrease access to care.
Access to healthcare remains a significant challenge in the United States, especially in rural
communities that have older, poorer, and sicker residents compared to their urban counterparts
(Health Resources and Services Administration, 2015). Unfortunately, rural areas also have fewer
primary care physicians and significant physician mobility (McGrail et al., 2017). Telehealth has
been identified as a potential strategy to increase healthcare access in communities that are
geographically isolated (Rosenblatt & Hart, 2000). Telehealth interventions can potentially help
people manage their chronic diseases and improve health outcomes and rural health disparities.
Once the effectiveness of a new medical treatment or technology has been established, it is often
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necessary to demonstrate the cost-effectiveness in order to increase adoption, especially when
start-up costs are high. One potential barrier to the adoption of telehealth interventions is the
uncertainty about start-up costs and the cost-effectiveness of these interventions. Research
assessing the cost effectiveness is critical for informing these decisions.
While there has been research to determine cost-effectiveness of telehealth, no study to-date
has shown conclusive evidence that these interventions are cost-effective in the United States. This
analysis compiles and reviews the existing literature on the cost-effectiveness of telehealth
interventions for chronic cardiovascular diseases and COPD.
II. Methodology
A literature search was undertaken to identify studies that assessed the cost-effectiveness
of telehealth interventions for chronic cardiovascular diseases and chronic obstructive pulmonary
disease (COPD) using the following two databases: PubMed and Scopus. Utilizing PubMed’s
medical subheadings (MeSH) resource by searching the subheadings telemedicine1 and cost benefit
analysis2 led to the identification of 753 articles. All 753 results were then transferred to EndNote
where abstracts were reviewed to determine if the study met the inclusion criteria for this review.
These criteria included studies published in English, published between January 1, 2000-August
31, 2017, included a cost-effectiveness evaluation, and looked at the impact on patients with COPD
and chronic cardiovascular disease, such as congestive heart failure, myocardial infarctions, and

Telemedicine is the MeSH entry term for Mobile Health, Health, Mobile, mHealth, Telehealth, and eHealth.
Cost benefit analysis is the MeSH enry term for: Analyses, Cost-Benefit; Analysis, Cost-Benefit; Cost-Benefit
Analyses; Cost Benefit Analysis; Analyses, Cost Benefit; Analysis, Cost Benefit; Cost Benefit Analyses; Cost
Effectiveness; Effectiveness, Cost; Cost-Benefit Data; Cost Benefit Data; Data, Cost-Benefit; Cost-Utility Analysis;
Analyses, Cost-Utility; Analysis, Cost-Utility; Cost Utility Analysis; Cost-Utility Analyses; Economic Evaluation;
Economic Evaluations; Evaluation, Economic; Evaluations, Economic; Marginal Analysis; Analyses, Marginal;
Analysis, Marginal; Marginal Analyses; Cost Benefit; Costs and Benefits; Benefits and Costs; Cost-Effectiveness
Analysis; Analysis, Cost-Effectiveness; and Cost Effectiveness Analysis.
1
2
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coronary heart disease. Exclusion criteria included studies that focused on diseases other than
chronic cardiac conditions and COPD, studies not written in English, studies that did not conduct
a physical telehealth intervention, and studies that did not include a cost effectiveness analysis.
This review process led to the identification of 27 articles that met the inclusion criteria – 17 of
these articles were research studies, 9 were literature reviews, and 1 was a meta-analysis. Of the
17 studies, 1 was conducted in Australia, 1 in Belgium, 2 in Canada, 1 in Denmark, 1 in Germany,
1 in the Netherlands, 1 in Spain, 2 in Taiwan, 3 in the United Kingdom, and 3 in the United States.3
III. Literature Review
i)

Individual Chronic Cardiovacular Disease Studies

Five studies performed outside the United States found that telehealth interventions were
comparable or more cost-effective than usual care for patients with chronic cardiovascular
diseases. For example, Ho et al. (2014) and Chen et al. (2013), researchers affiliated with their
Telehealth Center, conducted two studies at the National Taiwan University Health Center during
different time periods. The purpose of their studies was to assess the clinical outcomes and costeffectiveness of a telehealth program for patients with chronic cardiovascular diseases, including
1) coronary heart disease with or without percutaneous coronary intervention, 2) myocardial
infarction, 3) congestive heart failure, 4) arrhythmia, including bradyarrhythmia, tachyarrhythmia,
or ventricular arrhythmia with an implantable cardiac defibrillator implant, 5) diabetes mellitus, 6)
syncope, 7) =2 CAD risk factors with angina, and 8) other surgical or congenital heart conditions
(Chen et al., 2014).

One study, Henderson et al., examines the cost-effectiveness of telemedicine for patients with chronic conditions
including COPD and CHF
3
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Ho et al. (2014) retrospectively analyzed 575 patients who had joined a telehealth program and
compared them with 1178 patients undergoing usual care matched for sex, age, and Charlson
comorbidity index.4 Their study was conducted between December 2009 and April 2013. They
matched patients with chronic cardiovascular disease that entered the telehealth program with
patients that received usual care at their cardiovascular center using age, gender, and the Charlson
comorbidity index. The telehealth program transmitted biometric data from the patients’ homes,
and patients had access to decision-making support without seeing a doctor in person. This
program also included daily phone interviews. The researchers collected data on hospitalization,
emergency department (ED) visits, and medical costs from the hospital's database and the costs
were adjusted to the follow-up months. The cost-effectiveness of telehealth care over usual care
was assessed by using a bootstrap analysis method.5 The data is summarized in the following table:
Table 3.1. Monthly Cost Data of the Telehealth Program Conducted in Taiwan by Category
Control Group mean (SD)
Telehealth Group mean (SD)
ED visits
$37.30 (126.20)
$20.90 (66.60)
Hospitalizations
$878.20 (2,697.20)
$37.30 (126.20)
All Medical Costs
$1,163.60 (3,036.60)
$587.60 (1,497.80)
Even though the intervention cost an additional $224.80 per month, total monthly costs ($812.40)
in the Telehealth Group were still less than all medical costs in the control group, as seen in the
above table (Ho et al., 2014). Chen et al. (2013) conducted a quasi-experimental study between
November 2009 and April 2010 recruiting a total of 141 patients who received telehealth services
at the same hospital in the same program as Ho et al. (2014). They collected data on hospital visits

4

This index contains 19 categories of comorbidity and predicts the ten-year mortality for a patient who may have a
range of co-morbid conditions. Each condition is assigned a score of either 1 , 2, 3, or 4 depending on the risk of
dying associated with this condition. This helps to control for the impact of comorbidities on study outcomes .
5
A test or metric that relies on random sampling with replacement. Bootstrapping allows assigning measures of
accuracy (defined in terms of bias, variance, confidence intervals, prediction error or some other such measure) to
sample estimates.
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and hospital expenditures for six months before and after the opening of the hospital’s Telehealth
Center to assess clinical outcomes and cost-effectiveness of the program for patients with
cardiovascular disease. The study found that the intervention significantly reduced the monthly all
cause admission rate and the duration of all cause hospital stays. They also found that the
intervention significantly reduced the monthly inpatient costs and total cost per month (Chen et
al., 2013). From these studies, one can infer that in Taiwan’s integrated health care system, this
telehealth intervention was more cost-effective than usual care.
Whittaker and Wade’s study (2010) in the United Kingdom, a nation that has a government
run healthcare system, also found cost savings for a home telehealth-based cardiac rehabilitation
program. Their randomized controlled trial (RCT) included 120 participants; 60 participants each
randomly assigned to the telehealth program or to usual care. The telehealth program included a
cell phone with daily text messaging, a Wellness Diary, and access to a Wellness web portal. Usual
care consisted of the standard 6-week hospital-based outpatient rehabilitation program. On
average, the telehealth program saved providers £212 ($307.29)6 and saved patients £320
($463.84) in travel costs. Both groups showed significant improvements in both clinical
parameters and health-related quality of life measures. There were no significant differences in
health outomes between the two groups during the study period. (Whittaker and Wade, 2010).
Another RCT conducted in Belgium that also studied the effect of home telehealth-based cardiac
rehabilitation, found cost-savings for the provider, while also providing patients with better health
outcomes (Frederix et al., 2015). In this study, Frederix et al. (2015) randomized 140 patients into
two groups: a 24 week long tele-rehabilitation program plus usual care and usual care only. They

6

All exchange rates to US dollars used are of January 1st of the year the study was conducted.
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found that the intervention group had significant cost savings and fewer lost days to cardiovascular
rehospitalizations.
Another study conducted in the United Kingdom by Henderson et al. (2014) recruited 965
participants within a cluster RCT of 3230 patients to determine incremental cost per QALY
(quality-adjusted life year) gained for patients with CHF, COPD, and/or diabetes. QALY is a
generic measure of disease burden, including both the quality and the quantity of life lived. It is
used in economic evaluation studies to assess the value of the money spent on medical
interventions and is calculated by multiplying the utility score of being in a certain health state by
the time that the patient experienced that state. Study participants completed a questionnaire that
examined telehealth acceptability, effectiveness, and cost effectiveness. In conjunction, hospital
data was collected to determine cost-effectiveness. The probability of telehealth being cost
effective was 11% at a willingness to pay threshold of £30000 ($48,778.37) per QALY gained.
The probability exceeded 50% only if willingness to pay values exceeded £90,000 ($146,335.11).
Henderson et al. (2014) concluded that telehealth interventions have a low probability of being
cost-effective.
Boyne et al. (2013) also conducted an RCT to determine the cost-effectiveness of
telemonitoring of patients with CHF in the Netherlands. A total of 382 patients in 3 different
hospitals were randomized to either usual care or telemonitoring and followed for one year.
Hospital-related and home costs are estimated based on resource use multiplied by the appropriate
unit prices. Information was gathered from the participants through three monthly cost diaries and
questionnaires. There were no significant differences in annual costs per patient between groups.
Boyne et al. (2013) found that health-related quality of life showed slight improvement for the
telemonotoring group over usual care, but it was not significant. The researchers also found that
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at a threshold of €50,000 ($64,795) for cost of care, the probability of telemonitoring being costeffective was 48%. The cost effectiveness analysis shows a high level of decision uncertainty that
can probably be explained by the variability between the participating institutions.
Three studies published between 2001-2008 assess the cost-effectiveness of telehealth
interventions for the treatment of chronic cardiac diseases in the United States. Two of these
studies were conducted within the Department of Veterans Affairs Health System. In particular,
Darkins et al. (2008) followed patients participating in the Coordinated Care/Home Telehealth
(CCHT) program between July 2003 and December 2007. This program systematically
implements health informatics, home telehealth, and disease management technologies with the
purpose of helping patients live independently at home. CCHT provided services to patients with
diabetes mellitus (DM), congestive heart failure (CHF), hypertension (HTN), post-traumatic stress
disorder (PTSD), chronic obstructive pulmonary disease (COPD), and depression. They found that
CCHT had 25% fewer in-patient days of care and a 19% reduction in the number of hospital
admissions, six months after enrollment into the program compared to the six months before
enrollment. The patients enrolled in CCHT reported a mean satisfaction score rating of 86%,
though the study did not report a satisfaction score rating for patients receiving usual care. Noel et
al. (2004) conducted a study in the VA Connecticut Healthcare System (VACT) to determine
whether home telehealth, when integrated with the health facility's electronic medical record
system, reduces healthcare costs and improves quality of life outcomes relative to usual home
healthcare services for elderly high resource users with complex heart failure, chronic lung disease,
and/or diabetes mellitus by randomizing 104 patients to the telehealth program or usual care. The
researchers found that compared to the control group, the intervention significantly decreased at
six months the number of days of inpatient hospitalization (p < 0.0001), emergency room visits
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(p < 0.023), and A1c levels (p < 0.001). The third study, conducted by Jerant et al. (2001),
compared three hospital discharge care models for reducing CHF-related readmission charges: (a)
home telecare delivered via a 2-way video-conference device with an integrated electronic
stethoscope; (b) nurse telephone calls; and (c) usual outpatient care in a hospital in Southern
California. This was a small randomized control trial with 37 participants. After a year, mean CHFrelated readmission charges were 86% lower in the telecare group ($5850, SD $21,094) and 84%
lower in the telephone group ($7320, SD $24,440) than in the usual care group ($44,479, SD
$121,214). However, the difference between the telecare group and the nurse telephone group was
not statistically significant.
Table 3.2. Telehealth Studies for Patients with Chronic Cardiovascular Diseases
First Author

Year

Country

Boyne, J. J.
Chen, Y.
Cui, Y.
Darkins, A.
Frederix

2013
2013
2013
2008
2016

Netherlands
Taiwan
Canada
United States
Belgium

Henderson, C.
Ho, Y. L.

2013
2014

United Kingdom
Taiwan

Jerant, A. F.

2001

United States

Noel, H. C.
Sohn, S.
Whittaker, F.

2004
2012
2014

United States
Germany
United Kingdom

ii)

Type of
Intervention
Telemonitoring
Telemonitoring
Nurse call line
Telemonitoring
Telemonitoring

Number of
Participants
382
141
179
170257
140

QALYs
Used
Yes
No
Yes
No
Yes

CostEffective
No difference
Yes
Yes
Yes
Yes

Telemonitoring
Telemonitoring
Telemedicine
and Nurse Call
line
Telemonitoring
Telemonitoring
Telerehabilitation

965
575

Yes
No

No difference
Yes

37

No

Yes

104
1124
120

No
No
No

Yes
Yes
Yes

Individual Chronic Obstructive Pulmonary Disease (COPD) studies

While the results for the individual studies on cost-effectiveness for chronic cardiac diseases
are mostly positive, the results of studies that investigate the cost-effectiveness of telehealth
interventions for patients with COPD are far more varied. From 2013 to 2015, three studies
7

This number includes all Veterans Health Administration (VHA) patients receiving telehealth between July 2003
and December 2007.
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published in the United Kingdom assessed the cost-effectiveness of telemonitoring programs for
COPD patients after discharge from the hospital compared to usual care. The purpose of the
telemonitoring programs was to reduce emergency department visits and hospital admissions. All
three studies conclude that the cost of technology outweighed any cost benefit from the program.
These studies do report slightly better health outcomes in patients in the telemonitoring programs,
but not enough to justify the extra cost (Henderson et al., 2013, McDowell et al., 2015, and
Stoddart et al., 2015).
McDowell et al. (2015) identified 110 patients with COPD to study the effect of adding
telemonitoring to usual care in Northern Ireland. Their primary outcome was disease specific
quality of life over six months. They found that telemonitoring improved quality of life but was
not cost-effective. Stoddart et al. (2015) conducted an RCT that studied the cost and costeffectiveness of telemonitoring versus usual care for patients with COPD. They randomized 256
patients to either telemonitoring or usual care for a 12-month period. The study found the
intervention only had a 15% probability of being cost-effective at the usual threshold of £30,000
($37,984) per QALY. As stated earlier, Henderson et al. (2013) found that a telehealth intervention
for patients with COPD, CHF, and diabetes had a low probability of being cost-effective.
Interestingly, a RCT over a period of six months of a telemonitoring program conducted in
Australia found significant cost savings of AUD $2,931 (US$2992) (De San Miguel el al., 2013).
The study, however, did not find a significant difference in health outcomes (ED visits, hospital
admissions, and reduced length of stay) even though the telemonitoring group did have marginally
better outcomes. A telemonitoring study that randomized 57 patients with exacerbated COPD after
discharge conducted in Denmark also found significant cost savings for COPD patients joining the
intervention after hospital discharge versus usual care (Jakobsen et al., 2013).
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Two telemonitoring studies, one conducted in Canada and the other in Spain, reported
comparable results to the studies conducted in the United Kingdom. Jodar-Sanchez et al. (2014)
randomized 45 patients undergoing long-term oxygen therapy for severe COPD into a telehealth
group and a usual care group. The telehealth group used monitoring devices at home to send in
vital signs. When a patient triggered an alarm, medical staff triaged the patient and decided on next
steps. Paré et al. (2006) conducted a quasi-experimental study comparing the costs and effects of
19 patients in a telecare program to a comparable group of 10 patients receiving usual care. Both
studies concluded the cost of technology was too expensive to provide significant cost savings
(Jodar-Sanchez et al., 2014, and Paré et al., 2006).
Table 3.3. Telehealth Studies for Patients with COPD
First Author

Year

Country

De San Miguel, K.

2013

Henderson, C.

2013

Jakobsen, A.
Jodar-Sanchez, F.

2013
2014

McDowell, J. E.

2015

Paré, G.

2006

Stoddart, A.

2015

Australia
United
Kingdom
Denmark
Spain
United
Kingdom
Canada
United
Kingdom

iii)

Type of
Intervention

Number of
Participants

QALYs
Used

CostEffective

Telemonitoring

102

No

Yes

Telemonitoring

965

Yes

No

Telemonitoring
Telemonitoring

57
45

No
Yes

Yes
No

Telemonitoring

100

No

No

Nurse Call Line

29

No

No

Telemonitoring

256

Yes

No

Summary of previous literature reviews

Previously published reviews also show variation in the cost-effectiveness of telehealth
interventions for people with chronic cardiac diseases or COPD. There is considerable overlap in
the studies included in the reviews that fit the selection criteria. Udsen et al. (2014) conducted a
literature review of the costs and cost-effectiveness of telehealth for patients with COPD. This
review is the most in depth study and its findings are illustrative of those found in other literature
reviews. They assess six studies (three from North America and three from Europe) using the
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Consensus Health Economic Criteria list (CHEC list) to determine the quality of the economic
evidence presented in each paper. This methodology was created through the Delphi method8 with
23 international experts. Using this method of economic evaluation in systematic reviews should
make them more transparent, informative, and comparable (Evers et al., 2005). All studies report
the use of home monitoring devices that measure and transmit different physical indicators to
nurses who provide personalized feedback to patients during weekdays. In total, the six studies
include 559 COPD patients of whom 281 were randomized to the telehealth intervention. While
all six studies report a lower average cost per patient with telehealth plus usual care compared with
usual care alone, the authors found the quality of the economic evidence to be either mostly poor
(5 studies) or moderate (1 study), with CHEC list scores ranging from 21-68%. To provide some
perspective, within the CHEC list criteria, a score of greater than 75% is considered high quality,
between 50% and 75% is considered moderate quality, and less than 50% is considered poor
quality. These authors also recommend that healthcare decision-makers use caution before
implementing large scale telemedicine programs due to the lack of strong evidence in favor of
clinical cost-effectiveness.
Unfortunately, this is the only published review study that focuses exclusively on COPD
patients. The remaining systematic reviews on telemedicine interventions for COPD patients
combine studies on a variety of chronic conditions that focus on various outcomes including
intervention effectiveness and cost-effectiveness (Barlow et al., 2007, Botsis and Hartvigsen,
2008, Ekeland et al., 2010, Elbert et al., 2014, and Mistry et al., 2014). A possible reason for this
is the paucity of studies conducted on telemedicine interventions for patients with COPD. Barlow
et al. (2007) only found 3 studies on this topic, Botsis and Hartvigsen (2008) found 5 studies,

8

A forecasting process framework based on the results of multiple rounds of questionnaires sent to a panel of
experts.
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Ekeland et al. (2010) found 1 study, and Elbert et al. (2014) found 4 studies. These literature
reviews come to similar conclusions about the lack of strong evidence showing the costeffectiveness of telehealth interventions as Udsen et al. (2014).
Unlike COPD, there are more reviews of telehealth interventions that focus on heart failure
patients. Grustam et al. (2014), another group of European researchers, concluded that studies were
inconclusive with regard to the cost-effectiveness of telehealth interventions for chronic heart
failure (CHF) patients. They selected 32 studies for data extraction and a critical appraisal of the
economic evaluation. Not all studies selected were used in their analysis because they do not
include their own cost effectiveness analysis. Most studies did not present a comparison of both
costs and effects between telehealth intervention and usual care. In addition, many did not include
telehealth investment costs. The few studies that assessed cost-effectiveness comprehensively
showed that telehealth interventions were cost saving with slight improvement in effectiveness, or
comparably effective with similar cost to usual care. Jerant and Nesbitt (2005), in another review,
examined the evidence of cost effectiveness of telehealth interventions for patients with heart
failure. They found 5 prior systematic reviews on the effectiveness/cost-effectiveness of telehealth
interventions and 33 RCTs. Both Grustam et al. (2014) and Jerant and Nesbitt (2005) excluded
most of the articles chosen because they did not include enough information to conduct a costeffectiveness analysis and concluded that there was a lack of necessary data to prove or disprove
the cost effectiveness of telehealth interventions for patients with heart failure.
In 2013, the United Kingdom’s National Health Service (NHS) conducted a technology
assessment of telemonitoring programs after recent discharge in heart failure patients (Pandor et
al., 2013). Their literature search identified 3,060 articles. Through their inclusion criteria, 6 RCTs
were added to the 15 trials identified from the previous systematic reviews to be included in their
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systematic review and network meta-analyses9. They found telemonitoring during office hours
was the most cost-effective strategy with an estimated incremental cost-effectiveness ratio (ICER)
of £11,873 ($19,305) per quality-adjusted life-year (QALY) compared with usual care, whereas
human telephone support had an ICER of £228,035 ($37,0773) per QALY compared with
telemonitoring during office hours. They did conclude that their findings were based on less than
optimal data and that further research is needed (Pandor et al., 2013). Ten years earlier, Louis et
al. (2003), another group of British researchers, reviewed 5 studies that assessed the costeffectiveness for heart failure patients and also concluded that more research is needed. Thus,
similar to the literature review of COPD, these researchers could not conclude that telehealth
interventions for CHF patients were cost effective.
Table 3.4. Previously Published Reviews
First Author

Year

Study Description

Cost-Effective

Barlow, J.

2007

Unable to determine

Botsis, T.

2008

Ekeland, A.
G.
Elbert, N. J.

2010

Review of studies of home telecare for
patients with chronic conditions
Review of studies of home telecare for
patients with chronic conditions
Review of reviews of all telemedicine
interventions

2014

Review of reviews and meta-analyses of
telehealth interventions for patients with
somatic diseases

Grustam, A.
S.

2014

Jerant, A. F.

2005

Louis, A. A.

2003

Mistry, H.

2014

Cost-effectiveness of telehealth
interventions for chronic heart failure
patients
Cost-effectiveness of heart failure
disease management incorporating
telehealth
Review of telemonitoring for the
management of heart failure
Critical appraisal of published
systematic reviews assessing the costeffectiveness of telemedicine studies
including COPD and CHF

Attention should be given to the
development and evaluation of strategies to
implement effective/cost-effective eHealth
initiatives in daily practice, rather than to
further strengthen current evidence
Without full economic analyses the costeffectiveness of telehealth interventions in
chronic heart failure remains unknown
Cost-effectiveness of these programs is
unproven

Users felt telecare led to cost reduction
Not enough information to conclude the costeffectiveness of telemedicine interventions

More study is needed before conclusions of
cost-effectiveness can be determined
Conclusions cannot be drawn on the costeffectiveness of telemedicine applications
based on the methodological flaws in the
economic analysis of the studies included in
the reviews

Network meta-analysis, in the context of a systematic review, is a meta-analysis in which multiple treatments (that
is, three or more) are being compared using both direct comparisons of interventions within randomized controlled
trials and indirect comparisons across trials based on a common comparator (Li et al., 2011).
9
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Pandor, A.

2013

Systematic review and meta-analysis of
telemonitoring after recent discharge in
patients with heart failure

Udsen, F. W.

2014

Systematic review of the cost and costeffectiveness of telehealth for patients
suffering from chronic obstructive
pulmonary disease

Despite wide variation in usual care and
remote monitoring strategies, costeffectiveness analyses suggest that
telemonitoring during office hours was an
optimal strategy
Quality of the economic evidence was poor,
no definite conclusions can be made

V. Limitations and Strengths of the Literature
The literature on cost-effectiveness of telehealth interventions has many limitations. First, there
is a limited amount of research conducted on the topic for patients with chronic cardiovascular
conditions and COPD. These included many studies with small sample sizes. Also, all the most
recent research was done in Europe and Asia. It is difficult to draw conclusions from different
countries because they have varying health systems. Many of the international studies were
conducted in countries with universal healthcare coverage. The most current American study was
published in 2008. All three American studies were done in the Veterans Administration Health
System, which is not reflective of the rest of the United States’ healthcare system where most
people receive their care.
The 9 literature reviews discussed conclude that studies with a stronger economic analysis
component need to be conducted. These reviews looked at studies done in Australia, Europe, North
America, and Taiwan. One reason for this limitation may be due to the United States’ government
restriction on using the measure of “dollars per quality adjusted life year (QALY) as a threshold
to establish what type of health care is cost effective or recommended” (The Patient Protection and
Affordable Care Act, 2010) for the Medicare program. The Patient-Centered Outcomes Research
Institute (PCORI) is therefore limited in the types of analyses it is able to support.
Another limitation of the research is the variability in the cost-effectiveness of the same
intervention depending on contextual factors such as study population demographics, local and
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regional hospital environment, availability of social supports, and others. Providers need to be
aware of the research to be sure it can be replicated in their setting.
Another challenge to determining cost-effectiveness of telehealth programs is that many
studies include multiple diseases and people with multiple co-morbidities. The likelihood of a
person having co-morbidites increases with age, so it is difficult to determine the cost-effectiveness
of a program for a singular chronic condition. Multiple studies reviewed included people with
CHF, COPD, and/or diabetes to circumvent this issue. Also, these studies included multiple types
of telehealth programs including telemonitoring and telecare. The technology costs for different
types of telehealth vary wildly which makes it challenging to draw conclusions about the costeffectiveness of telehealth programs as a whole. Lastly, it is difficult to generalize costeffectiveness when countries have different thresholds for assessing cost-effectiveness.
One of the strengths of this literature is the range of studies and study protocols that have been
performed and that might serve as pilots for future studies. Also, the research included in this
review studied different interventions in different countries. This too could be a basis for future
research.
IV. Discussion
The current paucity of cost-effectiveness studies on telehealth, particularly in the United States,
is an important barrier that may be slowing the implementation of these interventions and
programs. As the population of the United States ages, the need for the improved management of
chronic diseases such as COPD and CHF will continue to increase . Providing better care at lower
costs is a critical goal moving forward. Many of the studies to-date looking at the cost-effectiveness
of telehealth are limited by small sample sizes. There is a possibility that bringing telehealth
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programs to scale can result in cost savings. In addition, the rapidly changing technology and costs
of technology impact their cost-effectiveness and the generalizability of previous studies.
If the United States’ Congress amends the restriction on funding research using QALYs,
PCORI could broaden its support for cost-effectiveness studies, including those evaluating
telehealth interventions. Cost is a major barrier to the adoption of telehealth services in the United
States (Lin et al., 2018). If more studies are able to demonstrate cost-effectiveness, this may lead
to greater adoption of these interventions.
Due to the limitations of the research, it is difficult to conclude if telehealth is a promising
approach. Studies conducted on the cost-effectiveness of telehealth for patients with chronic
cardiovascular diseases showed promising results, yet the studies conducted for patients with
COPD did not conclusively show cost-effectiveness. Previous literature reviews also could not
definitively conclude that telehealth was cost-effective. These reviews all call for further research
before any conclusions can be made.
VI. Conclusions
In spite of the promise of telehealth interventions and programs to improve care and reduce
costs for patients with chronic cardiovascular disease and COPD, based on currently available
research, it is difficult to conclude if they are cost-effective. Due to the lack of U.S. studies, small
sample sizes, and inconclusive results of previous studies, more research is needed. Innovations
in health information technology will continue to increase the opportunities for telehealth
interventions as well as the cost-benefit tradeoffs. Thus, there is critical need for research that
evaluates the cost-effectiveness of these new approaches. As the burden of chronic diseases
continues to grow in an aging U.S. population, leveraging technology to improve access to care
will remain a critical strategy, especially for disadvantaged and geographically isolated
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populations. Ensuring that these new technologies are both effective and cost-effective is an
important research priority.
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